Reply to Bishara et al., Huggan et al., and Lawrence et al.

Clinical Infectious Diseases

Volumn 45, Issue 12, 2007, Pages 1649-1651

  Zar, Fred A ^a   Davis, Melinda B ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; METRONIDAZOLE; VANCOMYCIN;

ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; BACTERIUM ISOLATION; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE; COLON RESECTION; CONTROLLED CLINICAL TRIAL; DIARRHEA; DISEASE SEVERITY; FECES CULTURE; HUMAN; LETTER; PATHOGENESIS; PRIORITY JOURNAL; RELAPSE; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 40949103444     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/523717     Document Type: Letter

References (11)

1. Bishara J, Wattad M, Paul, M. Vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea. Clin Infect Dis 2007; 45:1646-7 (in this issue).
2. Huggan PJ, Murdoch DR. Vancomycin therapy for severe Clostridium difficile-associated diarrhoea. Clin Infect Dis 2007; 45:1647-8 (in this issue).
3. Lawrence SJ, Dubberke ER, Johnson S, Gerding DN. Clostridium difficile-associateddisease treatment response depends on definition of cure. Clin Infect Dis 2007; 45:1648 (in this issue).
4. Zar FA, Bakkanagari SR, Moorthi KM, Davis MB. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 2007; 45:302-7.
5. McDonald LC, Coignard B, Dubberke E, et al. Recommendations for surveillance of Clostridium difficile-associated diarrhea. Infect Control Hosp Epidemiol 2007; 28:140-5.
6. Karanfil LV, Murphy M, Josephson A, et al. A cluster of vancomycin-resistant Enterococcus faecium in and intensive care unit. Infect Control Hosp Epidemiol 1992; 13:195-200.
7. Boyle JF, Soumakis SA, Rendo A, et al. Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant Enterococci. J Clin Microbiol 1993; 31:1280-5.
8. Carmeli Y, Eliopoulos GM, Samore MH. Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus. Emerg Infect Dis 2002; 8:802-7.
9. Donskey CJ, Chowdhry TK, Hecker MT, et al. Effect of antibiotic therapy on the density of vancomycin-resistant Enterococci in the stool of colonized patients. N Engl J Med 2000; 343:1925-32.
10. Teasley DG, Gerding DN, Olson MM, et al. Prospective randomized trial of metronidazole versus vancomycin for Clostridium difficile-associated diarrhea and colitis. Lancet 1983; 2:1043-6.
11. Wenisch C, Parschalk B, Hasenhundl M, Hirschl AM, Graninger W. Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea. Clin Infect Dis 1996; 22:813-8.